Clinical Trial Update: Proton Magnetic Spectroscopy in Children and Adolescents With ADHD Before and After Treatment With OROS Methylphenidate [Phase 4]

View source ↗

Summary

Phase 4 study update examining brain chemistry via Proton Magnetic Spectroscopy in children and adolescents with attention-deficit/hyperactivity disorder before…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• OROS-Methylphenidate (methylphenidate, osmotic release formulation)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: ADHD | Phase 4 | Status: COMPLETED | Results posted: 2011-05-05